Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Nov;4(6):639–642. doi: 10.1128/cdli.4.6.639-642.1997

Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.

M Devesa 1, Y E Khudyakov 1, F Capriles 1, L Blitz 1, H A Fields 1, F Liprandi 1, F H Pujol 1
PMCID: PMC170632  PMID: 9384281

Abstract

Antibody reactivities to hepatitis C virus (HCV) antigens and to synthetic peptides derived from different parts of the HCV genome (core, NS4, and NS5) were evaluated in HCV-infected hemodialysis patients. In the RIBA 3 assay, NS5 was significantly less recognizable by sera of hemodialysis patients compared to other HCV-infected subjects. Among hemodialysis patients, those coinfected with hepatitis B virus (HBV) (positive for hepatitis B surface antigen [HBsAg+]) showed a reduction in reactivity to C33 and C100. Sera of only 23% of the hemodialysis patients (37 of 161) reacted with more than three of eight peptides tested, significantly fewer than the 60% (12 of 20) of the sera of other HCV-infected patients tested (P = 0.001). This immunosuppression was also manifested by a reduced frequency of recognition of additional peptides on follow-up. An even more reduced reactivity was observed among the HBV-coinfected patients (HBsAg+). The low-responder hemodialysis patients were not infected with any particular genotype of HCV, and the same HCV genotypes observed in the whole group of hemodialysis patients (1a, 1b, 2a, and 3a) were found circulating in the low-responder group. Even in this low-responder population, the good performance of two peptides (peptide 716, corresponding to a portion of the core, and peptide 59, corresponding to a portion of NS4) corroborates the immunodominance of the conserved epitopes within these peptides.

Full Text

The Full Text of this article is available as a PDF (141.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chisari F. V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29–60. doi: 10.1146/annurev.iy.13.040195.000333. [DOI] [PubMed] [Google Scholar]
  2. Couroucé A. M., Barin F., Botté C., Lunel F., Maisonneuve P., Maniez M., Trepo C. A comparative evaluation of the sensitivity of seven anti-hepatitis C virus screening tests. Vox Sang. 1995;69(3):213–216. doi: 10.1111/j.1423-0410.1995.tb02597.x. [DOI] [PubMed] [Google Scholar]
  3. Couroucé A. M., Le Marrec N., Girault A., Ducamp S., Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion. 1994 Sep;34(9):790–795. doi: 10.1046/j.1537-2995.1994.34994378281.x. [DOI] [PubMed] [Google Scholar]
  4. Fornairon S., Pol S., Legendre C., Carnot F., Mamzer-Bruneel M. F., Brechot C., Kreis H. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation. 1996 Jul 27;62(2):297–299. doi: 10.1097/00007890-199607270-00025. [DOI] [PubMed] [Google Scholar]
  5. García-Samaniego J., Soriano V., Bravo R., González-Lahoz J., Muñoz F. Viral replication in patients with multiple hepatitis virus infections. Gastroenterology. 1994 Jul;107(1):322–323. doi: 10.1016/0016-5085(94)90104-x. [DOI] [PubMed] [Google Scholar]
  6. Goldblum S. E., Reed W. P. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med. 1980 Oct;93(4):597–613. doi: 10.7326/0003-4819-93-4-597. [DOI] [PubMed] [Google Scholar]
  7. Kao J. H., Chen P. J., Yang P. M., Lai M. Y., Wang T. H., Chen D. S. Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C. J Med Virol. 1996 Jun;49(2):87–90. doi: 10.1002/(SICI)1096-9071(199606)49:2<87::AID-JMV3>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  8. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9524–9528. doi: 10.1073/pnas.87.24.9524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Liaw Y. F. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology. 1995 Oct;22(4 Pt 1):1101–1108. doi: 10.1016/0270-9139(95)90615-0. [DOI] [PubMed] [Google Scholar]
  10. Lok A. S., Chien D., Choo Q. L., Chan T. M., Chiu E. K., Cheng I. K., Houghton M., Kuo G. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology. 1993 Sep;18(3):497–502. [PubMed] [Google Scholar]
  11. Muller G. Y., Zabaleta M. E., Arminio A., Colmenares C. J., Capriles F. I., Bianco N. E., Machado I. V. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int. 1992 Apr;41(4):1055–1058. doi: 10.1038/ki.1992.160. [DOI] [PubMed] [Google Scholar]
  12. Nagasaka A., Hige S., Kurosawa M., Yoshida J., Karino Y., Toyota J., Matsushima T., Asaka M. Nucleotide sequences of the hepatitis C virus core region in patients without anti-core antibody. J Med Virol. 1996 Jun;49(2):91–94. doi: 10.1002/(SICI)1096-9071(199606)49:2<91::AID-JMV4>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  13. Ohkawa K., Hayashi N., Yuki N., Hagiwara H., Kato M., Yamamoto K., Eguchi H., Fusamoto H., Masuzawa M., Kamada T. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol. 1994 Oct;21(4):509–514. doi: 10.1016/s0168-8278(94)80094-4. [DOI] [PubMed] [Google Scholar]
  14. Pujol F. H., Khudyakov Y. E., Devesa M., León G., Blitz-Dorfman L., Monsalve F., Lambert S. B., Kalinina T. Y., Liprandi F., Fields H. A. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome. Viral Immunol. 1996;9(2):89–96. doi: 10.1089/vim.1996.9.89. [DOI] [PubMed] [Google Scholar]
  15. Pujol F. H., Loureiro C. L., Devesa M., Blitz L., Parra K., Beker S., Liprandi F. Determination of genotypes of hepatitis C virus in Venezuela by restriction fragment length polymorphism. J Clin Microbiol. 1997 Jul;35(7):1870–1872. doi: 10.1128/jcm.35.7.1870-1872.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pujol F. H., Ponce J. G., Lema M. G., Capriles F., Devesa M., Sirit F., Salazar M., Vásquez G., Monsalve F., Blitz-Dorfman L. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol. 1996 Jul;34(7):1633–1636. doi: 10.1128/jcm.34.7.1633-1636.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosa C., Osborne S., Garetto F., Griva S., Rivella A., Calabresi G., Guaschino R., Bonelli F. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis. J Virol Methods. 1995 Oct;55(2):219–232. doi: 10.1016/0166-0934(95)00060-8. [DOI] [PubMed] [Google Scholar]
  18. Simon N., Couroucé A. M., Lemarrec N., Trépo C., Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int. 1994 Aug;46(2):504–511. doi: 10.1038/ki.1994.301. [DOI] [PubMed] [Google Scholar]
  19. Wang Y. F., Brotman B., Andrus L., Prince A. M. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. J Infect Dis. 1996 Apr;173(4):808–821. doi: 10.1093/infdis/173.4.808. [DOI] [PubMed] [Google Scholar]
  20. Zhang Z. X., Chen M., Sönnerborg A., Weiland O., Sällberg M. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins. J Infect Dis. 1995 May;171(5):1356–1359. doi: 10.1093/infdis/171.5.1356. [DOI] [PubMed] [Google Scholar]
  21. van Doorn L. J., Kleter B., Pike I., Quint W. Analysis of hepatitis C virus isolates by serotyping and genotyping. J Clin Microbiol. 1996 Jul;34(7):1784–1787. doi: 10.1128/jcm.34.7.1784-1787.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. van Doorn L. J., Kleter B., Stuyver L., Maertens G., Brouwer H., Schalm S., Heijtink R., Quint W. Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles. J Hepatol. 1994 Jul;21(1):122–129. doi: 10.1016/s0168-8278(94)80148-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES